Skip to main content
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
As of Mar 31
GeneralUnited States4 sourcesNeutral

LEO Pharma Presents New 12-Month Real-World Data for Tralokinumab at AAD 2026

MADISON, N.J.--(BUSINESS WIRE)--Mar 30, 2026--

BW
business wire
via The Joplin Globe - Corroborated by 3 others
LEO Pharma Presents New 12-Month Real-World Data for Tralokinumab at AAD 2026

Source Verification

Corroboration Score: 4

This story was independently reported by 4 sources. Click any source to read the original article.

Comments

0 comments
Be respectful and constructive.
Loading comments...